250,252 Tirzepatide and GLP-1 receptor agonists may decrease absorption of oral contraceptives due to delayed gastric emptying, however the evidence is inconsistent.275 As a precaution to avoid unplanned pregnancy, current product information for tirzepatide includes advice that women should switch to a non-oral contraceptive or add a barrier method of contraception for four weeks after initiation, and for four weeks after each dose escalation
However, many doctors still hesitate to prescribe these medications, and insurance coverage remains inconsistent
For patients exploring peptide combinations, understanding your individual biomarkers and genetic predispositions can significantly refine conversations with your provider about whether such stacking aligns with your specific health goals and risk profile
Programs that offer subscription-based medication services often cost upwards of $300 per month, and these non-FDA approved compounded GLP-1 medications raise serious concerns due to variability in dosage, potential for harmful additives, and lack of rigorous safety and efficacy testing